HDM2 ANTIBODY FOR USE IN TREATING CANCER
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
May 19, 2022
app pub date -
Feb 18, 2020
filing date -
Feb 18, 2020
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The invention provides an antibody or antibody fragment selective for HDM-2, an HDM-2 splice variant, or fragment thereof. The invention also provides a method of treating cancer, said method consisting of, consisting essentially of, or comprising administering to a subject in need thereof a therapeutic amount of an antibody or antibody fragment that is selective for membrane bound HDM-2, and any splice variants thereof.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully